poractant alfa

Poland

Drugs containing this active substance

  • CUROSURF

    The medicine is used to treat and prevent respiratory distress syndrome (RDS) in newborns, especially premature infants, who are born with a deficiency of natural surfactant.

    Form: suspension for inhalation and bronchial use

    Active substance Dosage
    poractant alfa 80 mg/ml

    ATC: R07AA02

    Manufacturer: Chiesi Farmaceutici SpA

  • CUROSURF

    The medicine is used for the treatment and prevention of respiratory distress syndrome (RDS) in newborns, especially premature infants, who are born with a deficiency of natural surfactant.

    Form: suspension for inhalation and bronchial use

    Active substance Dosage
    poractant alfa 80 mg/ml

    ATC: R07AA02

    Manufacturer: Chiesi Farmaceutici S.p.A.